ArticleDiseases (Basel, Switzerland)2026

Factors Associated with GLP-1 Receptor Agonist Use in Patients with Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Retrospective Propensity-Score Matched Analysis.

Georgios Vournas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.